Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Nephrogenic diabetes insipidus secondary prevention

Introduction

Overview

Overview

AVPR2is the only gene known to be associated with X-linked nephrogenetic diabetes insipidus. AQP2is the only gene known to be associated with autosomal recessive and autosomal dominant nephrogenetic diabetes insipidus.

Secondary Prevention

Secondary Prevention

Surveillance

  • Monitoring of growth in infants and children
  • Periodic measurement of serum sodium concentration to identify unrecognized hyperosmolality and early dehydration. Note: Urine output and urine specific gravity are useless as indicators of hydration status.
  • Annual renal ultrasound evaluation to monitor for hydronephrosis and megacystis [Shalev et al 2004]

Testing of Relatives at Risk

It is appropriate to evaluate at-risk infants as early as possible to allow for prompt diagnosis and treatment to reduce morbidity from hypernatremia, dehydration, and dilation of the urinary tract

Molecular Genetic Testing

Clinical Uses

  • Diagnostic testing
  • Carrier testing
  • Prenatal diagnosis

Clinical Testing

  • Sequence analysis
  • Sequence analysis of the AVPR2 gene detects almost 95% of disease-causing mutations in individuals with X-linked NDI.
  • Sequence analysis of the AQP2 gene detects almost 95% of disease-causing mutations in individuals with autosomal recessive or autosomal dominant NDI.
  • Linkage analysis. Linkage analysis may be performed:
  • To confirm cosegregation of a potential pathogenic mutation with disease in individual families and
  • As an ancillary test to obtain preliminary data prior to the completion of sequence analysis. Linkage testing cannot be used to confirm the diagnosis of NDI [Arthus et al 2000].
References

References

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]